Top member reports
Straws
Sort by:
Recent
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#First patient imaged in Phase
stale
Has imaged the first patient in its registrational Phase III 64Cu-SAR-bisPSMA diagnostic trial in participants with biochemical recurrence (BCR) of prostate cancer, AMPLIFY (NCT06970847) 1, at XCancer in Omaha, Nebraska (NE).
Just the CU6 cash position,
- Quarterly Activities/Appendix 4C Cash Flow Report:
https://hotcopper.com.au/threads/ann-quarterly-activities-appendix-4c-cash-flow-report.8561064/
Clarity's cash balance at 31 March 2025 was $95.1 million
Last
$2.16
Change
0.010(0.47%)
Mkt cap !
$694.1M
